Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Eur J Neurol. 2019 Mar 25;26(9):1235–1239. doi: 10.1111/ene.13940

Table 1.

Clinical characteristics of C9orf72 expansion carriers. N/A- not available. Educational level denoted Bachelor’s degree (B), Master’s degree (M.S.), Doctorate (Ph.D.), High School (HS), or General Educational Development Test (GED). ALSFRS-R: revised amyotrophic lateral sclerosis functional rating scale. MMSE: mini-mental state examination. ALS-CBS: amyotrophic lateral sclerosis cognitive behavioral score. TMA: Trailmaking A, TMB: Trailmaking B, LNS: Letter-Number-Sequence, sec: seconds. CSF biomarkers include Aβ, total-tau (t-tau), and phosphorylated tau (p-tau).

Participant Age Gender Site of
Onset
Disease
Duration
(years)
ALSFRS-R
(/48)
MMSE
(/30)

ALS-CBS
(/21)
Ed
1 64 Female Spinal 1.57 13 N/A N/A B
2 60 Male N/A N/A N/A 30 N/A M.S.
3 60 Male Bulbar 1.21 37 30 17 B
4 65 Female Bulbar 3.67 22 27 10 N/A
5 64 Male Spinal 4.19 21 23 16 M.S.
6 69 Male Spinal 2.67 25 24 8 Ph.D.
7 57 Female N/A N/A N/A 25 N/A GED
8 68 Female Bulbar 2.25 39 30 20 HS
9 60 Male Spinal 1.94 36 30 N/A HS
Avg 63.0 ± 4.0 56% Male N/A 2.50 ± 1.09 28 ± 9.8 27.4 ± 3.0 14.2 ± 5.0
Control cohort demographics (n= 18)
63.5 ± 5.3 50% Male N/A N/A N/A 29.9 ± 0.4 N/A N/A